Company Overview - Ceribell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions [3] - The company has developed the Ceribell System, a novel point-of-care electroencephalography (EEG) platform designed for acute care settings [2][3] - The Ceribell System combines portable hardware with AI-powered algorithms for rapid diagnosis and continuous monitoring of neurological conditions [2] Product Details - The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity [2] - It is currently utilized in intensive care units and emergency rooms across the U.S. [2] Upcoming Events - Jane Chao, Ph.D., CEO and Co-founder of Ceribell, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, at 7:30 a.m. PST [3]
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference